➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Harvard Business School
Merck
Medtronic
Boehringer Ingelheim

Last Updated: June 15, 2021

DrugPatentWatch Database Preview

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE Drug Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Losartan Potassium And Hydrochlorothiazide, and when can generic versions of Losartan Potassium And Hydrochlorothiazide launch?

Losartan Potassium And Hydrochlorothiazide is a drug marketed by Alembic Pharms Ltd, Apotex, Aurobindo Pharma, Cadista Pharms, Hikma, Ipca Labs Ltd, Lupin Ltd, Macleods Pharms Ltd, Mylan, Prinston Inc, Sandoz, Teva Pharms, Torrent Pharms, Unichem, Watson Labs, and Zydus Pharms Usa Inc. and is included in sixteen NDAs.

The generic ingredient in LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.

Drug patent expirations by year for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Recent Clinical Trials for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Jiao Tong University School of MedicinePhase 4
Kyushu UniversityPhase 3
Federico II UniversityPhase 4

See all LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE clinical trials

Pharmacology for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

US Patents and Regulatory Information for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Unichem LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 204832-002 Jul 21, 2017 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Sandoz LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 077948-003 Aug 19, 2010 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Watson Labs LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 200180-003 Jan 12, 2011 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Prinston Inc LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 204901-001 Nov 6, 2017 AB RX No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
McKesson
AstraZeneca
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.